A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the…

Overview of attention for article published in Frontiers in immunology, November 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 4 X users

patent: 1 patent

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,808 followers.

RT @ArcinovaUK: General inhibition of the complement system is known to increase susceptibility to infection. A promising new avenue for th…

General inhibition of the complement system is known to increase susceptibility to infection. A promising new avenue for therapy has been discovered through a single-domain antibody that mimics pathogenic anti-compliment activity. https://t.co/ToNKaTtSQ…

RT @dmastellos: A new complement C5-targeting single-domain antibody discovered by phage display #complement_therapeutics #MAC #hemolysis #…

A new complement C5-targeting single-domain antibody discovered by phage display #complement_therapeutics #MAC #hemolysis #drugdiscovery https://t.co/lxeZMbDKOH

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.